According to the statistics of dolphin stock data, as of the closing, the stock price of Chengyi Pharmaceutical was 23.27 yuan, with a rise and fall of 10.02%, a turnover rate of 5.70%, and a transaction of 216 million yuan throughout the day.
01. Real-time funds
Today, the stock's main funds flowed in 105 million yuan, outflow of 72.31 million yuan, and net inflow of 32.38 million yuan, of which the net inflow of 31.05 million yuan was 1.3229 million yuan, the net outflow of 23.13 million yuan, and the net outflow of 9.2458 million yuan in small orders.
02. Industry ranking
The industry to which this stock belongs is the pharmaceutical manufacturing industry. A total of 125 companies in the industry rose, 80 companies fell, and the leading stock was Chengyi Pharmaceutical , with an increase of +10.02%. Judging from the ranking of the main net inflows in the sector, Chengyi Pharmaceutical today ranked 18th in the industry. Today, the main funds in the pharmaceutical manufacturing industry flowed in 20.284 billion yuan, 20.016 billion yuan outflowed, and a net inflow of 267 million yuan, with an overall increase and decline of +1.06%.
ranking | name | rise and fall | main inflow | main outflow | main inflow | main inflow | main inflow | transaction amount |
---|---|---|---|---|---|---|---|---|
1 | Guizhou Sanli | +10.02% | 330 billion | 167 billion | 163 billion | 1163 billion | 603 billion | |
2 | Weiming Pharmaceutical | +5.77% | 835 billion | 682 billion | 153 billion | 1771 billion | ||
3 | 1 Hengrui Pharmaceutical | 1111111111 | +1.89% | 1561 billion | 1410 billion | 151 billion | 2689 billion | |
4 | 1 Hualan Biologics | +1.77% | 591 billion | 452 billion | 1.139 billion | 11.53 billion | 1.153 billion | 11. l10|
5 | Fosun Pharmaceutical | +3.45% | 740 billion | 659 billion | 812768 million | 1460 billion |
03. Funding trend
Chengyi Pharmaceutical cumulative rise and fall in the past 20 days was 22.22%, and the main force cumulative net outflow was 10.8671 million yuan during the period. As of today's closing, the total market value of Chengyi Pharmaceutical is 3.886 billion yuan.
Time period | cumulative rise and fall | main force cumulative net inflow | cumulative transaction amount | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3 days | 14.01% | 297861 million | 3 million | 3 | 3 pm | 3 pm | 3 pm | 3 pm | 3 pm | 3 pm | 3 pm | 3 pm | 5 pm | pm 1114.35% pm pm 111907 39 pm pm 115 pm pm 115 pm pm 115 pm pm 115 pm pm 115 pm pm 115 pm pm 115 pm pm 115 pm pm 115 pm pm 115 pm pm 115 pm pm 115 pm
10 | 26.06% | 289065 million | 767 billion | ||||||||||
20 | 22.22% | -108671 million | -108671 million | 340 billion |
04. Texture analysis
The company's main business: research and development, production and sales of chemical raw materials and preparations. .
As of March 31, 2020, Chengyi Pharmaceutical's operating income was 152 million yuan, and its net profit attributable to the parent company's shareholders was 24.4928 million yuan, an increase of 1.54% year-on-year.
No institution has conducted research on Chengyi Pharmaceutical in the past three months, and the stock has received low attention from institutions.
Click to download the Dolphin Stock APP, and the smart market-oriented free experience for life
Disclaimer: The information provided on this page is for investors' reference only and does not constitute any investment advice.